Search Results  for '600285.SS'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Henan Lingrui Pharmaceutical Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

02 May 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - HENAN LINGRUI PHARMACEUTICAL CO., LTD. (600285-SH)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

01 May 2015 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Henan Lingrui Pharmaceutical Co., Ltd.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

04 Apr 2015 Wright Reports 56 $75.00

Henan Lingrui Pharmaceutical Co., Ltd. (600285) - Financial Analysis Review

Henan Lingrui Pharmaceutical Co., Ltd. (600285) - Financial Analysis Review Summary Henan Lingrui Pharmaceutical Co., L...

31 Mar 2015 GlobalData 20 $125.00

Is Henan Lingrui Pharmaceutical Co., Ltd. a Good Long-Term Investment?

22 Oct 2014 Sadif Analytics Prime 12 $25.00

Henan Lingrui Pharmaceutical Co., Ltd. (600285) - Financial Analysis Review

Henan Lingrui Pharmaceutical Co., Ltd. (600285) - Financial Analysis Review Summary Henan Lingrui Pharmaceutical Co., L...

07 Oct 2014 GlobalData 20 $125.00

Henan Lingrui Pharmaceutical Co., Ltd. (600285) - Financial Analysis Review

Henan Lingrui Pharmaceutical Co., Ltd. (600285) - Financial Analysis Review Summary Henan Lingrui Pharmaceutical Co., L...

11 Aug 2014 GlobalData 21 $125.00

Are Henan Lingrui Pharmaceutical Co., Ltd. Investors in for a Bumpy Ride?

29 Jul 2014 Sadif Analytics Prime 12 $25.00

Company Snapshot - Henan Lingrui Pharmaceutical

A director at Henan Lingrui Pharmaceutical sold 337,500 shares at 2.646CNY and the significance rating of the trade was 72/10...

10 Jul 2014 Directors Deals Ltd. 1 $12.00

Henan Lingrui Pharmaceutical Co., Ltd. (600285) - Financial Analysis Review

Henan Lingrui Pharmaceutical Co., Ltd. (600285) - Financial Analysis Review Summary Henan Lingrui Pharmaceutical Co., L...

04 Jun 2014 GlobalData 21 $125.00